Related Experiment Video
Updated: Jan 17, 2026

07:03
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023
1.4K
How to build a thriving integrative oncology programme
Irene Martyniuk1, Victoria Kennedy2, Judith Rose3
1Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA imartyniuk@mgb.org.
BMJ Supportive & Palliative Care
|September 22, 2025
Summary
Integrative oncology (IO) programs are essential for cancer care. This guide offers leaders tools for establishing and sustaining successful IO programs, enhancing patient treatment and survivorship.
Area of Science:
- Oncology
- Healthcare Management
Background:
- Integrative oncology (IO) programs are increasingly standard in cancer care.
- Evidence supports the efficacy and patient benefits of IO.
- Systematic, evidence-based care requires specialized knowledge and planning.
Purpose of the Study:
- To equip IO program leaders and administrators with tools for program development and maintenance.
- To provide guidance for launching new IO programs and revitalizing existing ones.
- To outline management and logistical essentials for IO program establishment and sustainability.
Main Methods:
- A preconference workshop was offered at the Society for Integrative Oncology 2024 Annual International Conference.
- Key recommendations and critical steps were outlined for IO program leaders.
- Management and logistical essentials were described, building on prior clinical expertise.
Main Results:
- The workshop provided essential tools for global IO program leaders and administrators.
- The article outlines critical steps for launching new IO programs.
- Guidance is provided for revitalizing existing IO programs and ensuring sustainability.
Conclusions:
- Effective planning and management are crucial for successful integrative oncology programs.
- The provided recommendations support the establishment and sustainability of IO initiatives.
- This resource aids in delivering systematic, patient-centered integrative oncology care.
Related Concept Videos
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K

